Research programme: bradykinin B1 receptor antagonists - ElanAlternative Names: Benzamide B1 receptor antagonists - Elan; ELN 441958
Latest Information Update: 03 Dec 2007
At a glance
- Originator Elan Pharmaceuticals
- Class Analgesics
- Mechanism of Action Bradykinin B1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 03 Nov 2006 Preclinical trials in Pain in USA (unspecified route)